Newswise — Another promising clinical trial for the bioartificial kidney is offering researchers even more hope that within the next few years the device will be available to save lives of patients with acute renal failure. The latest University of Michigan Health System-led study reveals that short-term replacement of renal cell function using the renal tubule assist device, or RAD – the living cell cartridge that is key to the function of the bioartificial kidney – significantly reduces mortality risk and speeds recovery of kidney function for patients with acute renal failure resulting from acute kidney injury.
